BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33471966)

  • 1. A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy.
    Kimura Y; Okumura T; Morimoto R; Kazama S; Shibata N; Oishi H; Araki T; Mizutani T; Kuwayama T; Hiraiwa H; Kondo T; Murohara T
    ESC Heart Fail; 2021 Apr; 8(2):1359-1368. PubMed ID: 33471966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy.
    Verdonschot JAJ; Hazebroek MR; Wang P; Sanders-van Wijk S; Merken JJ; Adriaansen YA; van den Wijngaard A; Krapels IPC; Brunner-La Rocca HP; Brunner HG; Heymans SRB
    Circ Heart Fail; 2018 Nov; 11(11):e005220. PubMed ID: 30571196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy.
    Kubanek M; Sramko M; Maluskova J; Kautznerova D; Weichet J; Lupinek P; Vrbska J; Malek I; Kautzner J
    J Am Coll Cardiol; 2013 Jan; 61(1):54-63. PubMed ID: 23287372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy.
    Dziewięcka E; Totoń-Żurańska J; Wołkow P; Kołton-Wróż M; Pitera E; Wiśniowska-Śmiałek S; Khachatryan L; Karabinowska A; Szymonowicz M; Podolec P; Rubiś P
    Adv Clin Exp Med; 2020 Mar; 29(3):285-293. PubMed ID: 32207584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive factors of left ventricular reverse remodeling in patients with idiopathic or secondary dilated cardiomyopathy].
    Cai H; Fang Z; Weng Z; Jin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jan; 38(1):81-88. PubMed ID: 33177028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Tissue Reverse Remodeling After Guideline-Directed Medical Therapy in Idiopathic Dilated Cardiomyopathy.
    Xu Y; Li W; Wan K; Liang Y; Jiang X; Wang J; Mui D; Li Y; Tang S; Guo J; Guo X; Liu X; Sun J; Zhang Q; Han Y; Chen Y
    Circ Heart Fail; 2021 Jan; 14(1):e007944. PubMed ID: 33185117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential predictive value of cardiac mechanics for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Fang Q; Li S; Liu W; Tao X; Huang K; Hu M; Feng Z; Gong L
    ESC Heart Fail; 2023 Dec; 10(6):3340-3351. PubMed ID: 37697922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy.
    Ishii S; Inomata T; Fujita T; Iida Y; Ikeda Y; Nabeta T; Yanagisawa T; Naruke T; Mizutani T; Koitabashi T; Takeuchi I; Ako J
    Heart Vessels; 2016 Dec; 31(12):1960-1968. PubMed ID: 26920939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.
    Ruiz-Zamora I; Rodriguez-Capitan J; Guerrero-Molina A; Morcillo-Hidalgo L; Rodriguez-Bailon I; Gomez-Doblas JJ; de Teresa-Galvan E; Garcia-Pinilla JM
    Int J Cardiol; 2016 Jan; 203():1114-21. PubMed ID: 26651150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.
    Kuchynka P; Podzimkova J; Marek J; Danek BA; Vitkova I; Kreidlova M; Roblova L; Kovarnik T; Simek S; Horak J; Habasko J; Linhart A; Palecek T
    ESC Heart Fail; 2024 Apr; 11(2):859-870. PubMed ID: 38204216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.
    Dal Ferro M; Stolfo D; Altinier A; Gigli M; Perrieri M; Ramani F; Barbati G; Pivetta A; Brun F; Monserrat L; Giacca M; Mestroni L; Merlo M; Sinagra G
    Heart; 2017 Nov; 103(21):1704-1710. PubMed ID: 28416588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of coronary microvascular dysfunction for left ventricular reverse remodelling in dilated cardiomyopathy.
    Kan A; Leng Y; Li S; Lin F; Fang Q; Tao X; Hu M; Gong L
    Front Cardiovasc Med; 2023; 10():1301509. PubMed ID: 38111885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy.
    Ikeda Y; Inomata T; Iida Y; Iwamoto-Ishida M; Nabeta T; Ishii S; Sato T; Yanagisawa T; Mizutani T; Naruke T; Koitabashi T; Takeuchi I; Nishii M; Ako J
    Heart Vessels; 2016 Apr; 31(4):545-54. PubMed ID: 25686768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy.
    Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study.
    Nabeta T; Inomata T; Fujita T; Iida Y; Ikeda Y; Sato T; Ishii S; Maekawa E; Mizutani T; Naruke T; Koitabashi T; Inoue Y; Ako J
    J Cardiol; 2017 Aug; 70(2):185-191. PubMed ID: 27979675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late gadolinium enhancement for re-worsening left ventricular ejection fraction in patients with dilated cardiomyopathy.
    Nabeta T; Ishii S; Ikeda Y; Maemura K; Oki T; Yazaki M; Fujita T; Naruke T; Inomata T; Ako J
    ESC Heart Fail; 2021 Feb; 8(1):615-624. PubMed ID: 33270357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence and predictors of left ventricular reverse remodeling in patients with recent onset dilated cardiomyopathy on tailored medical therapy].
    Zhang J; Zou CH; Huang Y; Zhou Q; Zhang YH; Lyu R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):315-20. PubMed ID: 27112609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T1 mapping and late gadolinium enhancement for the diagnosis of dilated cardiomyopathy].
    Cui Q; Yu J; Ge X; Gao G; Liu Y; Shen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1506-1510. PubMed ID: 33541506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathy.
    Merlo M; Masè M; Vitrella G; Belgrano M; Faganello G; Di Giusto F; Boscutti A; Gobbo M; Gigli M; Altinier A; Lesizza P; Barbati G; Ramani F; De Luca A; Morea G; Cova MA; Stolfo D; Sinagra G
    Am J Cardiol; 2018 Aug; 122(3):490-497. PubMed ID: 29958711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
    Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
    ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.